These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of molecular imaging in the characterization of renal masses. Meyer AR; Allaf ME; Rowe SP; Gorin MA Curr Opin Urol; 2018 Mar; 28(2):159-165. PubMed ID: 29319547 [TBL] [Abstract][Full Text] [Related]
4. Clinical Performance of Technetium-99m-Sestamibi SPECT/CT Imaging in Differentiating Oncocytic Tumors From Renal Cell Carcinoma in Routine Clinical Practice. Schober JP; Braun A; Ginsburg KB; Bell S; Castro Bigalli AA; Chen M; Wang R; Magee D; Bukavina L; Handorf E; Yu JQ; Chen DYT; Greenberg RE; Smaldone MC; Viterbo R; Correa AF; Uzzo RG; Kutikov A J Urol; 2023 Sep; 210(3):438-445. PubMed ID: 37378576 [TBL] [Abstract][Full Text] [Related]
5. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma. Shandal V; Kumar R BJU Int; 2010 Jul; 106(1):132-3. PubMed ID: 20553479 [No Abstract] [Full Text] [Related]
6. A 99mTc-Labeled Ligand of Carbonic Anhydrase IX Selectively Targets Renal Cell Carcinoma In Vivo. Krall N; Pretto F; Mattarella M; Müller C; Neri D J Nucl Med; 2016 Jun; 57(6):943-9. PubMed ID: 26912427 [TBL] [Abstract][Full Text] [Related]
7. 99m Tc-MIBI SPECT/CT in a Case of Renal Oncocytosis. Zhao Q; Dong A; Zuo C; Yang B Clin Nucl Med; 2023 Sep; 48(9):830-832. PubMed ID: 37486723 [TBL] [Abstract][Full Text] [Related]
8. Spontaneous Regression of a Low-Grade Renal Cell Carcinoma With Oncocytic Features After Renal Mass Biopsy. Srivastava A; Meyer AR; Pierorazio PM; Rowe SP; Allaf ME; Gorin MA Clin Genitourin Cancer; 2018 Dec; 16(6):e1083-e1085. PubMed ID: 30097254 [No Abstract] [Full Text] [Related]
9. Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CT. Lawrentschuk N; Lee FT; Jones G; Rigopoulos A; Mountain A; O'Keefe G; Papenfuss AT; Bolton DM; Davis ID; Scott AM Urol Oncol; 2011; 29(4):411-20. PubMed ID: 19523858 [TBL] [Abstract][Full Text] [Related]
10. Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study. Hekman MC; Rijpkema M; Muselaers CH; Oosterwijk E; Hulsbergen-Van de Kaa CA; Boerman OC; Oyen WJ; Langenhuijsen JF; Mulders PF Theranostics; 2018; 8(8):2161-2170. PubMed ID: 29721070 [TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT in a patient affected by renal collecting duct (Bellini) carcinoma. Bertagna F; Fisogni S; Tardanico R; Simeone C; Cunico SC; Giubbini R Clin Nucl Med; 2012 Oct; 37(10):986-8. PubMed ID: 22955073 [TBL] [Abstract][Full Text] [Related]
12. Use of Almassi N; Gorin MA; Purysko AS; Rowe SP; Kaouk J; Allaf ME; Campbell SC; Rhee A Urology; 2018 Mar; 113():206-208. PubMed ID: 29174943 [TBL] [Abstract][Full Text] [Related]
13. [64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma. Minn I; Koo SM; Lee HS; Brummet M; Rowe SP; Gorin MA; Sysa-Shah P; Lewis WD; Ahn HH; Wang Y; Banerjee SR; Mease RC; Nimmagadda S; Allaf ME; Pomper MG; Yang X Oncotarget; 2016 Aug; 7(35):56471-56479. PubMed ID: 27437764 [TBL] [Abstract][Full Text] [Related]
15. Novel Imaging Methods for Renal Mass Characterization: A Collaborative Review. Roussel E; Capitanio U; Kutikov A; Oosterwijk E; Pedrosa I; Rowe SP; Gorin MA Eur Urol; 2022 May; 81(5):476-488. PubMed ID: 35216855 [TBL] [Abstract][Full Text] [Related]
16. Unusual metastatic sites from renal cell carcinoma detected by 18F-FDG PET/CT scan. Aurangabadkar H; Ali Z Clin Nucl Med; 2013 Dec; 38(12):e471-3. PubMed ID: 23603603 [TBL] [Abstract][Full Text] [Related]
17. Does F-18 FDG-PET still play a role in metastatic renal cell carcinoma? Mennitto A; Grassi P; Verzoni E; Ratta R; Procopio G J Med Imaging Radiat Oncol; 2017 Apr; 61(2):250-251. PubMed ID: 28070961 [No Abstract] [Full Text] [Related]
18. 'Case of the Month' from the Specialist Centre for Kidney Cancer, Royal Free London Hospital, UK: Miller J; Campain N; Boydell AR; Warren H; Vito I; Neves J; Mumtaz F; Bex A; El-Shiekh S; Wagner T; Tran MGB BJU Int; 2022 Jan; 129(1):28-31. PubMed ID: 34967994 [No Abstract] [Full Text] [Related]
19. Better late than early: FDG-PET imaging in metastatic renal cell carcinoma. Harrison MR; George DJ Clin Cancer Res; 2011 Sep; 17(18):5841-3. PubMed ID: 21926167 [TBL] [Abstract][Full Text] [Related]
20. PET/CT with (124)I-cG250: great potential and some open questions. Khandani AH; Rathmell WK; Wallen EM; Ivanovic M AJR Am J Roentgenol; 2014 Aug; 203(2):261-2. PubMed ID: 25055257 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]